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Muscle gene electrotransfer is increased by the antioxidant
tempol in mice
B Markelc1, G Tevz1, M Cemazar1, S Kranjc1, J Lavrencak2, B Zegura3, J Teissie4,5 and G Sersa1
Electropermeabilization (EP) is an effective method of gene transfer into different tissues. During EP, reactive oxygen species
(ROS) are formed, which could affect transfection efﬁciency. The role of generated ROS and the role of antioxidants in
electrotransfer in myoblasts in vitro and in Musculus tibialis cranialis in mice were, therefore, investigated. We demonstrate
in the study that during EP of C2C12 myoblasts, ROS are generated on the surface of the cells, which do not induce long-term
genomic DNA damage. Plasmid DNA for transfection (pEGFP-N1), which is present outside the cells during EP, neutralizes
the generated ROS. The ROS generation is proportional to the amplitude of the electric pulses and can be scavenged by
antioxidants, such as vitamin C or tempol. When antioxidants were used during gene electrotransfer, the transfection efﬁciency
of C2C12 myoblasts was statistically signiﬁcantly increased 1.6-fold with tempol. Also in vivo, the transfection efﬁciency of
M. tibialis cranialis in mice was statistically signiﬁcantly increased 1.4-fold by tempol. The study indicates that ROS are
generated on cells during EP and can be scavenged by antioxidants. Speciﬁcally, tempol can be used to improve gene
electrotransfer into the muscle and possibly also to other tissues.
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INTRODUCTION
Electropermeabilization (EP) is a physical method that enables the
introduction of molecules such as dyes, drugs or genetic material into
cells. By applying external electric ﬁeld pulses to living cells, a local
increase in transmembrane potential difference occurs. Under well-
deﬁned conditions, the membrane becomes transiently permeabilized,
which enables various molecules to enter the cell.1,2
EP is currently in clinical use for the delivery of cancer chemother-
apeutic drugs such as bleomycin or cisplatin (electrochemotherapy) in
the treatment of skin metastases or deep-seated tumors.3–5 Complete
responses of skin metastases, predominantly melanoma, are in the
range of 70–80%.6
EP was originally discovered for the delivery of plasmid DNA into
cells in vitro by Neumann et al. in 1982.7 Since the ﬁrst report of
successful gene electrotransfection of the skin,8 the method has been
increasingly used for the delivery of different types of DNA/RNA
molecules into cells in vitro and different tissues, including muscle and
tumors in vivo.9–19 Furthermore, gene electrotransfer has also proved
to be safe and effective in the treatment of cancer. A report on the ﬁrst
clinical study of gene electrotransfer, which used therapeutic gene
coding for interleukin-12 for the treatment of metastatic melanoma,
has already been published by Daud et al.20 There are also other
clinical studies in progress on muscle tissue for DNA vaccination,
systemicdelivery of therapeutic proteins and correction of gene defects
in muscles; therefore, the studies on muscle cell cultures and muscle
tissue are of special importance. Namely, good correlation between the
in vitro studies on C2C12 cells and in vivo studies on muscle tissue has
been demonstrated.21,22 In addition, gene therapy studies are on-going
in veterinary medicine, showing that the ﬁeld is rapidly expanding.23–26
Although EP has many advantages compared with viral transfection
methods, such as the lack of immunogenicity, ease of preparation
of large quantities of endotoxin-free plasmid DNA, control and
reproducibility of the method and the availability of electropulsators
approved for clinical use, there are some problems that must be
resolved before the method can become widely used.9,23 The main
problem is still the low expression efﬁciency of gene electrotransfer in
different tissues. Several attempts have, therefore, been made to
improve transfection efﬁciency, determination of appropriate pulse
parameters for speciﬁc tissue, the interval between plasmid injection
and the application of electric pulses for a speciﬁc tumor type and
degradation of tumor extracellular matrix.15,27–32 In addition, numerical
modeling was used to further increase the efﬁcacy of electrogene
transfer in muscle tissue.33
Previous reports have indicated that EP induces the generation of
reactive oxygen species (ROS), mainly O2
, which are generated on
the permeabilized part of the cell membrane during EP34 only when
the cells are reversibly permeabilized. These ROS can damage lipids,
proteins and DNA and, consequently, effect long-term cell survival. In
addition to that, there have been several studies reporting the induc-
tion of genes for radical scavenging molecules after EP.35–37 The
generation of ROS and their effect on cell survival after EP can be
avoided by adding antioxidant ascorbic acid,38,39 but the toxicity of
the compound alone is too high for safe usage in vivo. The impact of
generated ROS on gene electrotransfer is still not clear.
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www.nature.com/gtThe aim of our study was, therefore, to explore the generation of
ROS by the exposure of cells to electric pulses used for electrogene
therapy. In relation to this, the effect of ROS scavengers on the
transfection efﬁciency of electrotransfer of plasmid DNA encoding
green ﬂuorescent protein (GFP) to C2C12 myoblasts in vitro and
Musculus tibialis cranialis in mice was tested, as a model system. The
results may be indicative for other tissues that could beneﬁt from
increased transfection efﬁciency; predominantly tumors.
RESULTS
EP and survival of C2C12 mouse myoblasts
Cell survival and permeabilization of C2C12 cells in vitro were
determined for different electric pulse parameters: ranging from
4 to 8 electric pulses of 5ms duration of various amplitudes
(Figure 1). The results indicated that better cell survival of cells was
obtained with 4 or 6 electric pulses than with 8 electric pulses.
Furthermore, there was no difference in cell survival between 4 and
6 electric pulses at 500Vcm1, whereby cell permeabilization was
B70%, which is the amplitude of electric pulses that was selected for
further experiments.
EP-induced ROS generation on cells and neutralizing effect of
plasmid DNA
The generation of ROS was determined by lucigenin chemilumines-
cence, which is indicative of ROS generated outside of cells.34
An increase in ROS generation was detected in the range of electric
pulse amplitude starting at 300 up to 800Vcm1. Up to 500Vcm1,
a steady increase in ROS generation was detected, which reached
a 25-fold increase compared with the untreated control group
(Figure 2a). At higher amplitudes, a slight decrease in ROS
generation was observed. From our previous results, this appears
to be due to decreased cell viability and damaging effects of EP
on cells.38
The generated ROS were neutralized by the addition of plasmid
DNA (pEGFP-N1) into the cells’suspension prior to the EPof cells. In
the presence of plasmid DNA, the chemiluminescence intensity was
signiﬁcantly reduced at all amplitudes of electric pulses tested
(Figure 2a). There was a trend to less efﬁcient ROS scavenging at
the highest amplitudes of electric pulses tested, during which the cell
membranes were already severely affected by EP and cell survival was
also signiﬁcantly reduced. These results indicated that ROS generated
by EP interacted with DNA, which resulted in their neutralization by
plasmid DNA (pEGFP-N1).40
Based on these results and results on optimized EP of C2C12 cells,
6 pulses with 500Vcm1 were selected for further experiments,
whereby 40% of permeabilized cells remained viable.
Figure 1 Cell survival and permeabilization of C2C12 cells after EP. Survival
and permeabilization curves of the cells treated with different number of
pulses at different amplitude per distance ratios, 5ms duration and 1Hz
repetition frequency are presented.
Figure 2 EP-induced ROS on C2C12 cells which are scavenged by plasmid
DNA (pEGFP-N1) or antioxidants (tempol, vitamin C). Lucigenin
chemiluminescence measured after electrotransfection or EP (pulsing
parameters: 6 pulses, 5ms, 1Hz) (a) and after EP with the addition of
antioxidants (pulsing parameters: 6 500Vcm1,5 m s ,1 H z )( b). Data
represent the arithmetic mean±s.e.m. of 3–5 experiments normalized to
untreated control group and cell viability. Po0.05 was considered
statistically signiﬁcant. *Statistically different from groups 0–300Vcm1
and 500–600Vcm1, including the same groups with plasmid DNA,
**Statistically different from all groups, including the same group with
plasmid DNA except 600Vcm1, ***Statistically different from all groups,
including the same group with plasmid DNA except 500 and 700Vcm1,
****Statistically different from groups 0–300Vcm1, including the same
group with plasmid DNA, #Statistically different from groups 0Vcm1 with
plasmid DNA, ##Statistically different from groups 0–100Vcm1
with plasmid DNA, ###Statistically different from groups 0–600Vcm1 with
plasmid DNA.
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Gene TherapyAntioxidants scavenge the ROS generated by EP
Exposure of C2C12 myoblasts to EP of 500Vcm1 induced a
signiﬁcant increase in ROS generation on the cell membrane, up to
25-fold compared with untreated cells (Figures 2a and b). The
addition of antioxidants before or after EP (10s) of cells signiﬁcantly
decreased the amount of ROS detected. The change of pulsing buffer
conductivity due to the addition of scavengers did not affect the shape
of the electric pulses delivered on the sample. The ROS scavenging
effect of either vitamin C (4mM) or tempol (6mM) was equally
effective; the values detected were in the range of untreated control
cells, as well as in the range of cells exposed to antioxidants only
(Figure 2b).
EP induces small short-term nuclear DNA damage in cells but not
on naked plasmid DNA
The effect of EP on plasmid DNA integrity and genomic DNA was
tested. Plasmid DNA, pEGFP-N1 was exposed to different electric
pulse amplitudes (400–600Vcm1, 6 pulses, 5ms, 1Hz), and their
possible effect on plasmid DNA fragmentation (change in mobility)
was determined by agarose gel electrophoresis. The integrity of the
plasmid DNA was intact at all the electric pulse amplitudes tested,
from 400 to 600Vcm1 (Figure 4). As a positive control, bleomycin41
was used, which caused signiﬁcant plasmid fragmentation at 10 and
100mM (Figure 3a).
The damage of EP-induced ROS to genomic DNA in cells was
quantiﬁed by the formation of 8-oxoguanin performed immediately
after EP. At this early post-EP time, no oxidative genomic DNA
damage was detected, either after exposure of cells to EP only, or
plasmid (pEGFP-N1 plasmid) or a combination of the two (plasmid
and EP) (Figure 3b).
The level of DNA damage after EP at longer intervals after EP was
also evaluated by modiﬁed Comet assay, measuring DNA-strand
breaks and oxidized purines. The exposure of cells to electric pulses
(6 500Vcm1, 5ms, 1Hz) resulted in a small but signiﬁcant increase
of both DNA-strand breaks and formamidopyrimidine-DNA
glycosylase (Fpg) sensitive sites at 15 and 30min of recovery after
EP, which gradually decreased at 60min post-EP, demonstrating the
presenceofefﬁcient DNArepairmechanismsinC2C12cells(Figure4).
Similar behavior was also demonstrated by DNA damage induced by
tert-butyl hydroperoxide treatment (Figure 4).
All these experiments demonstrated that EP does not induce
damage to DNA directly but indirectly in the presence of cells, as
demonstrated by transient damage to genomic (nuclear) DNA. This
DNA damage is negligible and present only for a short period after EP.
Cytotoxicity of antioxidants alone or combined with DNA and EP
on cell survival
The effect of antioxidants alone or in combination with EP and
plasmid DNA on cell survival was determined. The exposure of cells to
vitamin C or tempol had some cytotoxic effect, but cell survival
remained higher than 70% at the highest doses of antioxidants tested
(Figure 5a). When antioxidants were added to the cells prior to or
after EP, cell survival was slightly decreased but not more than 50% in
comparison with EP alone (Figure 5a). When antioxidants were added
to the cells exposed to plasmid DNA and EP, cell survival was
decreased more with vitamin C than with tempol (Figures 5a and
b). Tempol decreased cell survival to B40%, while vitamin C to 4% at
the highest dose tested (25mM). Although not signiﬁcant, the effects
on cell survival were less pronounced with both tempol and vitamin C
when antioxidants were added after EP (Figure 5b). Based on these
results, we decided to use concentrations up to 6mM for vitamin C
and up to 10mM for tempol, which did not decrease cell survival
below B40% in further experiments.
Antioxidants increase electrotransfection efﬁciency in vitro
The effect of antioxidants on the electrotransfection of C2C12 cells
was measured by ﬂow cytometry and ﬂuorescence microscopy. Flow
cytometry demonstrated a statistically signiﬁcant increase in the
percentage of ﬂuorescence cells when tempol was added before EP.
Figure 3 The integrity of plasmid DNA (pEGFP-N1) and genomic DNA
damage after EP. Representative image of agarose gel electrophoresis of
plasmid DNA (pEGFP-N1) after EP or the addition of bleomycin (a)a n d
normalized ﬂuorescence intensity of FITC conjugate bound to 8-oxoguanine
after EP indicative of oxidative DNA damage (b). Pulsing parameters:
6400–600Vcm1, 5ms, 1Hz for (a)a n d6  500Vcm1, 5ms, 1Hz for
(b). Groups: 0V—plasmid DNA (pEGFP-N1), 400V—plasmid DNA (pEGFP-
N1)+EP 400Vcm1, 500V—plasmid DNA (pEGFP-N1)+EP 500Vcm1,
600V—plasmid DNA (pEGFP-N1)+EP 600Vcm1, bleomycin 1, 10,
100mM—plasmid DNA (pEGFP-N1)+bleomycin. Data in (b) represent the
arithmetic mean±s.e.m. of three experiments normalized to the untreated
control group: EP—electropermeabilization, DNA—pEGFP-N1 plasmid.
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(Figure 6a). At this setting, the median ﬂuorescence intensity of
transfected cells was also statistically increased by up to 1.8-fold
(Figure 6b). If tempol was added after EP of the cells (10s), no
signiﬁcant increase in transfection efﬁciency was detected (Figure 6a).
Fluorescent microscopy conﬁrmed the data from ﬂow cytometry; an
increased number of transfected cells was detected at 8mM tempol,
only when it was added to cells before EP (Figure 6c). Vitamin C had
no effect on the transfection efﬁciency of C2C12 cells; a decrease in
transfection efﬁciency was even detected (Figure 6a).
Tempol increases transfection efﬁciency in vivo in muscle
In vivo transfection efﬁciency was determined in the M. tibialis
cranialis in mice. Plasmid DNA (pEGFP-N1) mixed with tempol
was injected into the M. tibialis cranialis and the muscle leg was
electropulsated immediately thereafter. Analysis of ﬂuorescent images
of electrotransfected mice muscles (Figure 7b) demonstrated a 1.4
times increase in the transfected area at 12mM concentration of added
tempol in comparison with the control group on the 21st day after EP,
which was a statistically signiﬁcant increase (Figure 7a). The mean
ﬂuorescence intensity of the transfected area was not affected
(Figure 7a).
DISCUSSION
The results of this study indicate that during EP of C2C12 cells, ROS
are generated on the surface of the cells, which do not induce long-
term genomic DNA damage. Plasmid DNA, which is present outside
the cells during EP, neutralizes the ROS generated and, therefore,
becomes inactivated. ROS generation is proportional to the amplitude
of the electric pulses and can be scavenged by antioxidants, such as
vitamin C or tempol. When antioxidants are used during gene
electrotransfer, the transfection efﬁciency of C2C12 myoblasts is
increased, speciﬁcally, 1.6-fold by tempol. The in vivo, transfection
efﬁciency of M. tibialis cranialis in mice is also increased by tempol,
1.4-fold.
The generation of ROS after EP of Chinese hamster ovary cells has
already been reported.38,39,42,43 Gabriel and Teissie42 demonstrated on
Chinese hamster ovary cells that ROS are generated on the external
layer of the cell membrane in the cap, which is electropermeabilized.
The ROS generated were induced by exposure of the cells to 5 electric
pulses of 500Vcm1, a duration of 1ms, frequency 1Hz and were
detected by (Pam)-Aﬂuorescein with ﬂuorescence video microscopy
on the level of a single cell. This phenomenon, the generation of ROS
after EP of cells, was also detected with lucigenin and was dependent
on the parameters of the EP, such as the amplitude of electric pulses,
pulse duration and pulse number.39 Our study using lucigenin for the
detection of ROS conﬁrms previously published results, but on
different cell line (C2C12 myoblasts), with pulse parameters used
for gene electrotransfer (6 500Vcm1, 5ms, 1Hz).28 In this speciﬁc
model of muscle cells, we demonstrated that more ROS are generated
with increasing amplitude of electric pulses used. The complementa-
rities of the results between the two different detection methods
(Pam)-Aﬂuorescein, which detects the ROS on the membrane, and
lucigenin, which detects the ROS in the suspension close to the cell
surface, indicate that the ROS are also generated in or on the cell
membrane during the EP process in C2C12 cells. Moreover, several
studies have reported the induction of genes for radical scavenging
molecules after EP.35–37
Figure 4 Genomic DNA damage after EP. Genomic DNA damage was determined by modiﬁed Comet assay with repair enzyme Fpg after the exposure of cells
to EP or tert-butyl hydroperoxide. The results are presented as a percentage of tail DNA. Data are presented as quantile box plots. The edges of the box
represent the 25 and 75th percentiles (95% conﬁdence intervals), the mean is a solid line through the box. The white box plots represent exposure to
enzyme buffer (DNA-strand breaks), while dotted box plots represent exposure to Fpg enzyme (oxidized purines). Pulsing parameters: 6 500Vcm1,5 m s ,
1Hz. Groups: 0 buffer—negative control group without enzyme treatment; *statistically different from the control group with the same treatment,
+statistically signiﬁcantly different between buffer exposed groups and Fpg enzyme exposed groups.
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generation inside the cytoplasm after EP of cells. There is some
indication by Shil,44 who used 2’,7’,-dichlorodihydroﬂuorescein
diacetate for ROS detection and, under different experimental condi-
tions than ours, showed an increase in intracellular ROS generation
with increasing amplitude of electric pulses. Similar results were
obtained after ionizing radiation but at an B50% higher extent.
In our study, the presence of intracellular ROS was implicated
indirectly by measurement of genomic DNA damage. The indication
that DNA damage is generated by ROS and not by EP directly is
supported by the fact that damage to genomic DNA could not be
detected immediately after exposure of cells to EP, as demonstrated by
the 8-oxoG assay. Genomic DNA damage after a longer post-EP
interval was detected using the Comet assay. The genomic DNA
damage was minimal compared with the damage caused by
tert-butyl hydroperoxide, which was used as a positive control, and
transient (detected only at 15 and 30min intervals), showing effective
DNA repair within 60min after EP. In addition, we demonstrated that
exposure of plasmid DNA to different electric parameters did not
result in plasmid DNA fragmentation. Similar results were obtained by
Goldberg, who demonstrated that exposure of isolated genomic DNA
to EP of electric parameters used for gene electrotransfer does not
induce direct DNA damage/fragmentation.45
Plasmid DNA, which is present during EP, neutralized the generated
ROS. The oxidation of DNA in the presence of ROS that are generated
during the normal metabolic process in cells is a well-known
phenomenon that occurs naturally in every cell.40 If the cell is exposed
to oxidative stress, the oxidation of DNA is increased. If the plasmid
DNA used for electrotransfection reacts with ROS generated during
EP, the detection of ROS by lucigenin should, therefore, be reduced.
We demonstrated that the ROS derived chemiluminescence of luci-
genin was reduced when plasmid DNA was present around the cells
during EP. The addition of 10mg of plasmid DNA to the cells
completely prevented the detection of ROS by lucigenin after EP.
We observed the same effect on detection of ROS by the addition of
antioxidants such as vitamin C and tempol to cells exposed to EP. In
view of these data, we can assume that the generated ROS interacted
with plasmid DNA present during the EP of the cells.
In the next step, we tried to improve transfection efﬁciency by the
use of antioxidants. Electrotransfection is a multistep process1 that
requires the formation of DNA-cell membrane complexes for effective
transfection.46 The interaction between the ROS generated during the
application of electric pulses and plasmid DNA complexed with
the cell membrane could, therefore, affect the transfection efﬁciency.
The addition of ROS scavengers, antioxidants, to cells prior to EP
might neutralize the generated ROS as soon as they are formed and
the plasmid DNA in the DNA-cell membrane complexes would not be
affected. The electrotransfection efﬁciency could consequently be
improved. Indeed, our in vitro data indicate that the transfection of
pEGFP-N1 in the C2C12 cell line was increased by 60% when tempol
was added before EP, which indicates that, by modulating the
generated ROS, we can affect the transfection efﬁciency. The ROS
generated due to EP on the cell surface must affect the plasmid DNA
very rapidly, since there was no increase in transfection efﬁciency if
tempol was added after the EP. A positive effect of antioxidants, such
as ascorbic acid, on expression levels after electrotransfection has been
reported in plant cells,47 but to our best knowledge, there has been no
report of increased electrotransfection efﬁciency in animal cells in vitro
or in vivo following (due to) the addition of antioxidants.
In vivo, in mouse muscle, tempol increased transfection efﬁciency
by 40%. The transfection efﬁciency was increased when tempol was
mixed with plasmid DNA and injected together into the M. tibialis
cranialis, which was immediately thereafter exposed to EP.
The increase was evident only at a 12-mM tempol concentration.
The transfected area was increased but not the quantity of the GFP
in the cells, indicating that more muscle ﬁbers were transfected when
the antioxidant was present, while the amount of plasmid DNA
introduced in a single ﬁber was not changed compared with control.
Altogether, that means that a higher expression of GFP (number of
expressed proteins) was induced. A lower dose was probably not high
enough to scavenge enough generated ROS to affect transfection
efﬁciency. At a higher dose, the positive effect of tempol on scavenging
EP generated ROS was probably counteracted by additional ROS
formation caused by tempol-initiated lipid peroxidation,48 resulting in
a similar level of transfection efﬁciency as in control muscles exposed
to EP alone. We observed the same effect in vitro.
Tempol is widely used as a promoter of the metabolism of many
ROS. It has been used in many different studies in vitro and in vivo.
In vitro it has been shown that it can preserve mitochondria against
oxidative damage. In vivo in many preclinical models, it has been
demonstrated that tempol improved survival in several shock models
Figure 5 Cytotoxic effects of antioxidants (vitamin C and tempol) on C2C12
cells. Cell survival was determined after exposure of cells to different
concentrations of antioxidants (a) and combined with EP and pEGFP-N1
(EGT–EP+pEGPF-N1) (b). Pulsing parameters: 6 500Vcm1, 5ms, 1Hz.
Data represent arithmetic mean±s.e.m. of three experiments normalized to
untreated control group or to the group exposed only to EP or EGT, where EP
or EGT is present.
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Gene Therapyin mice, protecting many organs, including the heart and brain, from
ischemia/reperfusion damage, reducing the consequences of oxidative
stress and inﬂammation after radiation, reducing blood pressure and
so on. However, in humans, the compound has only been used as a
topical agent to prevent radiation-induced alopecia.48,49 To the best of
our knowledge, tempol has not been used as an agent to increase
transfection efﬁciency. The doses of tempol used in our study were
lower than the reported toxic doses for mice and rats49 and no side
effects were recorded.
The antioxidant tempol is, therefore, a promising compound,
which can also be used to improve electrotransfection efﬁciency in
tissues. Muscle is easy to transfect; however, there are other tissues,
such as skin and, especially, tumors, in which higher transfection
efﬁciency would result in a better clinical effect. Several approaches are
being investigated, especially in tumors, to increase transfection
efﬁciency, such as pulse parameter selection, modulation of
extracellular matrix, the time interval between DNA injection
and application of EP, plasmid preparation and so on.15,16,18,27–29,50
In the present study, we demonstrated the importance of ROS
generation after EP on transfection efﬁciency and showed that the




Mouse myoblast cell line C2C12 (ATCC, Rockville, VA, USA) was cultured in
Eagle’s Minimum Essential Medium (Gibco, Grand Island, NY, USA) supple-
mented with 10% fetal bovine serum, 10mM glutamin (Gibco BRL, Paisely,
UK), 350mgl 1, gentamycin (Krka, Novo mesto, Slovenia) and 1mll1
crystacillin (Pliva d.d., Zagreb, Croatia) in a 5% CO2 humidiﬁed incubator
at 371C.
Reagents
Cell permeable antioxidants, vitamin C—ascorbic acid and tempol—4-hydro-
xy-2,2,6,6-tetramethylpiperidine-1-oxyl, were purchased from Sigma-Aldrich
(St Louis, MO, USA). The concentrations used in the experiments were
prepared by dissolving the antioxidants in phosphate-buffered saline (PBS)
for in vitro and in dH2Of o rin vivo experiments. The concentrations of vitamin C
and tempol used in the in vitro experiments ranged from 2 to 25mM.I nt h e
Figure 6 Increased in vitro transfection efﬁciency of pEGFP-N1 plasmid into C2C12 cells after the addition of tempol before EP. Fraction of enhanced GFP
expressing cells (a) and normalized median ﬂuorescence intensity of enhanced GFP expressing cells (b). Images of cells electrotransfected with pEGFP-N1
plasmid acquired with ﬂuorescent microscope (c) (excitation: 460–490nm, emission: 505nm). Pulsing parameters: 6 500Vcm1,5 m s ,1 H z .D a t ai n
(a)a n d( b) represent arithmetic mean±s.e.m. of three to ﬁve experiments normalized to control group in which no antioxidants were added. Po0.05 was
considered statistically signiﬁcant. *Statistically different from control group and the same concentration of tempol after EP, **Statistically different from
control group, all tempol before EP groups except tempol 6mM and from tempol 8mM after EP. Groups in (c): plasmid+EP—EGT, pEGFP-N1
plasmid+EP+tempol 8mM—EGT+tempol 8mM, plasmid+EP+tempol 10mM—EGT+tempol 10mM, addition of antioxidant after EP—antioxidant after EP,
addition of antioxidant before EP—antioxidant before EP. Where no antioxidant was added, the treatment of cells was the same for both parallel groups.
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iodide (P4170, Sigma-Aldrich) was resuspended in EP buffer to a ﬁnal
concentration of 100mM. Lucigenin—9,9¢-Bis(N-methylacridinium nitrate) (Sig-
ma-Aldrich) was resuspended in PBS to a ﬁnal concentration of 5mM.
Agarose and ethidium bromide (10mgml1) for electrophoresis were
purchased from Sigma-Aldrich. The EcoR1 enzyme, corresponding buffer
(React3) and DNA ladder mix were bought from Fermentas Inc. (Glen Burnie,
MD, USA).
Plasmid pEGFP-N1 (Clontech Laboratories Inc., Mountain View, CA, USA),
encoding enhanced GFP was prepared from Escherichia coli cultures using the
Qiagen Endo-Free Plasmid Mega kit (Qiagen, Hilden, Germany) according to
the manufacturer’s instructions and diluted to a working concentration of
1mgml1.I na l lin vitro experiments, 10mg of DNA was used.
Normal melting point agarose, low melting point agarose and ethidium
bromide solution for the Comet assay were from Gibco (Gibco BRL). Fpg was a
gift from Dr Andrew R Collins (Department of Nutrition, University of Oslo,
Oslo, Norway) and concentrations of the enzyme were prepared according to
his protocol. All other chemical reagents were of the purest grade available and
all solutions were made using Mill-Q water.
In vitro EP/electrotransfection protocol
The C2C12 cells grown as a monolayer were collected and a cell suspension
with a concentration of 3.3107cellsml1 was prepared in EP buffer (EP
buffer: 125mM sucrose, 10mM K2HPO4, 2.5mM KH2PO4,2 m M MgCl26
H2O). Antioxidants, dH2O and/or plasmid DNA or propidium iodide were
added to the prepared cell suspension and 50ml of mixture was then placed
between two ﬂat parallel stainless steel electrodes with a 2-mm gap, connected
to a GT-1 electropulsator (University of Ljubljana, Faculty of Electrical
Engineering, Ljubljana, Slovenia) or Jouan PS 10 electropulsator (St Herblain,
France) and subjected to various numbers of square wave pulses (4, 6, 8) with
various amplitude per distance ratios (0–900Vcm1), 5ms duration and 1Hz
repetition frequency. After pulsing, the electrodes were washed with 100mlo f
1 PBS or dissolved antioxidant (antioxidant concentrations were calculated to
working volume of 150ml). Subsequently, the cells in a 150-ml volume were
incubated for 5min at room temperature, then the growth medium was added.
Thereafter, cell viability, permeabilization, survival and transfection were
determined as described below.
Cell permeabilization and viability
Cells were electropermeabilized (0–900Vcm1, 4–8 pulses, 5ms, 1Hz) in the
presence of 100mM propidium iodide (Sigma-Aldrich) dissolved in EP buffer.
Membrane re-sealing occurred 5min after pulse application, keeping inter-
nalized propidium iodide trapped. Cells were then analyzed by FACSCalibur
ﬂow cytometer (BD Biosciences, San Jose, CA, USA) to determine the
percentage of permeabilized cells (that is ﬂuorescent cells). Crystal violet
(Merck, Darmstadt, Germany) staining was used to determine the viability of
the cells 24h after EP.
Cell survival
Cell survival was determined by clonogenic assay. After a particular treatment, the
cells (300–800) were plated on 6cm petrie dishes with 4ml growth medium and
placed in a 5% CO2 humidiﬁed incubator at 371C. After 10–12 days, the colonies
were stained with crystal violet and then counted. Colonies of fewer than 50 cells
were ignored. Plating efﬁciency and the surviving fraction were calculated. The
experiments were performed in triplicate and repeated three times.
Cell transfection
The expression of GFP in the cells was monitored with an FACSCanto II ﬂow
cytometer (BD Biosciences) and ﬂuorescent microscope Olympus IX70 (exci-
tation: 460–490nm, emission: 505nm, Olympus, Hamburg, Germany). The
images were taken with a digital camera (DP 50, Olympus). After EP, the cells
were plated on 6cm petrie dishes with 4ml growth medium and placed in a 5%
CO2 humidiﬁed incubator at 371C. After 2 days, the cells were collected and
the number of GFP expressing cells was quantiﬁed by ﬂow cytometer.
A histogram of cell number against ﬂuorescence was recorded. The percentage
of GFP expressing cells represented the transfection efﬁciency. Transfection
efﬁciencies of samples treated with antioxidants were then normalized to an
untreated control sample (cells electropermeabilized in the presence of GFP) to
obtain normalized transfection efﬁciency.
In vitro ROS detection after EP
A concentration of 1, 25108cellsml1 was prepared in EP buffer. A total of
40ml of the suspension was mixed with either 10mlo fp l a s m i dD N A ,
antioxidants or dH2Oa n d5 0 ml of mixture was electropermeabilized as
described above. Immediately after pulsing, the electrodes were washed with
290ml of PBS buffer into 96-well plates (Corning Inc., New York, NY, USA) and
10mlo f5m M lucigenin was added. The cells were then immediately (10s) put
into a multimode microplate reader (Inﬁnite 200, Tecan, Ma ¨nnendorf, Switzer-
land) and chemiluminescence was measured every 3s for 300s. The acquired
Figure 7 Increased transfected area (area) and mean ﬂuorescence of
transfected area (mean ﬂuorescence) of electrotransfected M. tibialis
cranialis after the addition of tempol. Transfected area and mean
ﬂuorescence intensity were determined by analysis of the acquired images of
M. tibialis cranialis (a) and imaged with a ﬂuorescent stereomicroscope
(excitation: 470/40nm, emission: 525/50nm) (b). Pulsing parameters:
1600Vcm1, 100ms, 1Hz+480Vcm1, 100ms, 1Hz. Groups in (b):
plasmid+EP–control, plasmid+EP+tempol 6mM—tempol 6mM,
plasmid+EP+tempol 12mM–tempol 12mM, plasmid+EP+tempol 24mM—
tempol 24mM.D a t ai n( a) represent the arithmetic mean±s.e.m. of 13–35
mice legs normalized to the control group in which no antioxidants were
added. Po0.05 was considered statistically signiﬁcant. *Statistically
different from all other groups.
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curve represented the increased chemiluminescence signal due to ROS generation.
To determine the effect of antioxidants on in vitro ROS production, the
antioxidants were added in two different ways. First, the antioxidants were
added to the cell suspension after EP (290ml of antioxidant dissolved in 1 PBS
buffer) instead of PBS buffer and second, 10ml of antioxidants were added to
the cell suspension just before EP (o5s). The concentrations were calculated to
a working volume of 350ml. The data were normalized to the control group, in
which the cells were not subjected to EP and cell viability.
Determination of plasmid DNA integrity
In order to determine the effect of electric pulses on plasmid DNA integrity,
1ml of pEGFP-N1 plasmid was resuspended in 49mlo fE Pb u f f e r .T h em i x t u r e
was then exposed to electric pulses (6 500Vcm1, 5ms, 1Hz) or to different
concentrations of bleomycin (1, 10, 100mM) for positive control and then
incubated for 4h in a water bath at 371C, with shaking. After incubation, 7ml
of the sample was mixed with 1ml of EcoR1 enzyme and 2mlo fc o r r e s p o n d i n g
buffer (React3) and then incubated for 1h in a water bath at 371C, with
shaking. The restricted samples, containing 140ng of pDNA, were then
transferred to 1% agarose gel stained with ethidium bromide and electrophor-
esis run for 2h at 50Vcm1. An image of the gel was taken with the GelDoc-it
imaging system (UVP, Upland, CA, USA) under ultraviolet light.
Determination of oxidative DNA damage of genomic (nuclear)
DNA after EP
In order to determine whether EP causes any oxidative DNA damage to cells,
8-oxoguanine, which is formed from guanine after interaction of genomic DNA
with ROS, was quantiﬁed by OxyDNA test kit (8-oxoG assay; Merck KGaA,
Darmstadt, Germany). The cells were subjected to 6 square wave electric pulses
of 500Vcm1 amplitude per distance ratio, 5ms duration time and 1Hz
repetition frequency. Immediately (o5s) after EP, the cells were ﬁxed in 4%
formaldehyde and then permeabilized with 0.1% Triton and washed several
times with wash solution supplied with the kit. After washing, FITC conjugate,
which binds to 8-oxoguanin, was added to the cell pellet and the cells were
incubated for 60min at room temperature. The cells were again washed with
1 PBS and the cells were then analyzed by FACSCanto II ﬂow cytometer (BD
Biosciences). Histograms of cell number against ﬂuorescence were recorded.
The mean ﬂuorescence of the cell sample was then normalized to the untreated
control group.
Determination of nuclear DNA damage after EP
Single cell gel electrophoresis, also called the Comet assay, is a very sensitive
method for detecting DNA double-strand breaks and single-strand breaks,
alkali labile sites such as apurinic/apyrimidinic sites, DNA–DNA and DNA–
protein cross-links and single-strand breaks associated with incomplete excision
repair.51 The genomic oxidative DNA damage induced by EP was measured
with the modiﬁed Comet assay, as described by Collins et al.52 with minor
modiﬁcations,53 using lesion-speciﬁc DNA repair enzyme Fpg, which converts
oxidized purines to apyrimidinic sites and strand breaks.54,55 C2C12 cells were
electropermeabilized as described above and left in an incubator at 371Ci n5 %
CO2. For positive control of DNA damage, the cells were incubated for 15min
on ice with 100mM tBOOH (tert-butyl hydroperoxide, Sigma-Aldrich). After
15, 30, 45 and 60min of cell recovery at 371C, 30mlo fc e l ls u s p e n s i o nw a s
mixed with 70ml of 1% low melting point agarose and added to fully frosted
slides that had been covered with a layer of 1% normal melting point agarose.
The slides were subsequently lysed (2.5 M NaOH, 0.1 M ethylenediaminetetraa-
cetic, 0.01 M Tris, pH 10 and 1% Triton X-100) for 1h at 41C. After the lysis,
the slides were washed three times for 5min in endonuclease buffer solution
(40mM HEPES-KOH, 0.1 M KCl, 0.5mM EDTA, 0.2mgml–1 bovine serum
albumin, pH 8.0). A total of 50ml aliquots of Fpg solution or enzyme buffer
without Fpg were added to the gel, covered with a cover glass and incubated at
371C for 30min as described by the manufacturer. After the incubation, the
slides were placed in the electrophoresis solution (300mM NaOH, 1mM EDTA,
pH 13) for 20min to allow DNA unwinding, and electrophoresed for 20min at
25V (300mA). Finally, the slides were neutralized with 0.4 M Tris buffer (pH
7.5), stained with ethidium bromide (5mgml 1)a n da n a l y z e du s i n ga
ﬂuorescence microscope (Nikon Eclipse 800, Tokyo, Japan). Images of 50
randomly selected nuclei per experimental point were analyzed with image
analysis software Comet Assay IV (Perceptive Instruments, Haverhill, UK). The
results from two independent experiments performed each time in two parallels
are expressed as a percentage of tail DNA and are shown as box plots.
Experimental animals
Female C57Bl/6 mice were used in the experiments (Institute of Pathology,
Faculty of Medicine, University of Ljubljana, Slovenia). Experimental protocols
were in accordance with the guidelines for animal experiments of European
Union directives and a permit from the Ministry of Agriculture, Forestry and
Food of the Republic of Slovenia. (Permit no.: 34401-11/2009/6). The age of the
mice that were included in the experiments was between 12 and –16 weeks.
Mice were kept under speciﬁc pathogen-free conditions at a constant room
temperature (211C) and a 12-h light/dark cycle. Food and water were provided
ad libitum. Animals were subjected to an adaptation period of 1 week before
experiments. The experiments were performed three times. Experimental
groups consisted of 6–18 animals.
In vivo electrotransfection of M. tibialis cranialis
Both mouse hind legs were shaved and then depilated with hair removal cream
(Vitaskin, Krka d.d). To increase the randomization, each leg was assigned to
different experimental group. Before EP, the mice were anesthetized with
Isoﬂuran (Torrex Chiesi Pharma GmbH, Vienna, Austria). Muscle electro-
transfection was performed according to our previously described protocol.29
Brieﬂy, 20mg of DNA in 30mlo fd H 2O for the control group or 20mgo fD N A
in 20mlo fd H 2O mixed with 10ml of dissolved antioxidants was injected into
the muscle o5s before EP; EP was then performed with CLINIPORATOR
(IGEA s.r.l., Carpi, Italy). Transfection efﬁciency in vivo was monitored with a
ﬂuorescent stereomicroscope (excitation: 470/40nm, emission: 525/50nm,
SteREOLumar V.12, Carl Zeiss, Jena, Germany), equipped with an AxioCam
MRc5 digital camera (Carl Zeiss), on the 7th and 21st day after EP. The
transfected area was separated from the non-transfected area by determining a
threshold value for pixel intensity on every image. Pixels with greater intensity
than the threshold value gave the transfected area. Values were normalized to
the group in which no antioxidants were used. Transfection efﬁciency was
determined as the normalized ﬂuorescent area and the normalized mean
ﬂuorescence intensity of the ﬂuorescent area on images of M. tibialis cranialis.
ImageJ software (National Institute of Mental Health, Bethesda, MD, USA) was
used for image analysis.
Statistical analysis
All data were tested for normality of distribution using the Kolmogorov–
Smirnov test. Differences between experimental groups were statistically
evaluated by one-way analysis of variance followed by the Holm–Sidak test
for multiple comparisons. A P-value o0.05 was considered to be statistically
signiﬁcant. SigmaPlot Software (Systat Software, London, UK) was used for
statistical analysis and graphical presentation. For the Comet assay, one-way
analysis of variance (Kruskal–Wallis) was used to analyze differences between
treatments within each experiment. Dunnett’s test was used for comparison
versus the control; Po0.05 was considered to be statistically signiﬁcant.
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